Evidence map›Paper›PMID 29651327›Full record

ArticleDisease markers2018

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Simone Bier, Jörg Hennenlotter, Michael Esser, Sarah Mohrhardt, Steffen Rausch, Christian Schwentner, Moritz Maas, Susanne Deininger, Simon Walz, Jens Bedke and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Case Report: AFrontiers in oncology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Simone BierDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.ORCID 0000-0003-0189-1119
Jörg HennenlotterDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Michael EsserDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Sarah MohrhardtDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Steffen RauschDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.ORCID 0000-0002-6398-8701
Christian SchwentnerDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Moritz MaasDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Susanne DeiningerDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Simon WalzDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Jens BedkeDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.
Arnulf StenzlDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.ORCID 0000-0003-4207-9928
Tilman TodenhöferDepartment of Urology, Eberhard Karls University, Tuebingen, Germany.ORCID 0000-0003-4432-2741
University of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the performance of urine markers determined in urine samples from the bladder compared to samples collected from the upper urinary tract (UUT) for diagnosis of UUT urothelial carcinoma (UC). PATIENTS AND

methodsThe study comprised 758 urine samples either collected from the bladder (

resultsUUT UC was diagnosed in 59 patients (19.1%) (UUT urine) and 27 patients (7.2%) (bladder-derived urine). For UUT-derived samples, sensitivities for cytology, FISH, NMP22, and uCyt+ were 74.6, 79.0, 100.0, and 100.0, while specificities were 66.6, 50.7, 5.9, and 66.7%, respectively. In bladder-derived samples, sensitivities were 59.3, 52.9, 62.5, and 50.0% whereas specificities were 82.9, 85.0, 31.3, and 69.8%. In UUT-derived samples, concomitant bladder cancer led to increased false-positive rates of cytology and FISH.

conclusionsUrine markers determined in urine collected from the UUT exhibit better sensitivity but lower specificity compared to markers determined in bladder-derived urine. Concomitant or recent diagnosis of UC of the bladder can further influence markers determined in UUT urine.

Indexed as

Biomarkers, TumorCarcinoma, Transitional CellCystoscopyEarly Detection of CancerFemaleHumansIn Situ Hybridization, FluorescenceMaleNeoplasm GradingNeoplasm StagingNuclear ProteinsRetrospective StudiesSensitivity and SpecificityUreteroscopyUrologic NeoplasmsBiomarkers, Tumornuclear matrix protein 22Nuclear Proteins

Identifiers

PMID29651327
PMCPMC5831978
OpenAlexW2788251536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.